InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by Carter Percy H., Directeur Scientifique. Insider active across 1 companies, notably Blueprint Medicines Corp. Cumulatively, 4 reports have been logged. Total volume traded: €107k. The latest transaction was disclosed on 6 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€106,6481,908 shares@ €55.8953100.0% of flow
Common Stock
SEC:0001415889-22-006308:0·
08,750 shares0
Common Stock
SEC:0001415889-22-002441:0·
021,843 shares0
Common Stock
SEC:0001179110-21-006329·
021,843 shares0
Common Stock
SEC:0001179110-21-006329:0·
4 of 4 declarations
About Carter Percy H.
Percy H. Carter is the Chief Scientific Officer of Blueprint Medicines Corp. In this role, he oversees the company's research and development activities, focused on innovation in drug development. Blueprint Medicines is a biopharmaceutical company dedicated to discovering treatments for serious diseases. Percy H. Carter brings valuable scientific expertise, contributing to the advancement of the company's research.
